News | News By Subject | News by Disease News By Date | Search News

Urinary incontinence/urgency News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co. (MRK)     6/7/2017
FDA Panel Expresses Concerns Over Allergan (AGN)-Serenity Drug for Nighttime Urination     10/18/2016
Sophiris Bio Inc. (SPHS) Tanks As Phase 3 Data Indicates Drug May Not Be Effective     12/16/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Pfizer Inc. (PFE) Reports Positive Results in Studies of Toviaz, Pristiq, Chantix     1/24/2013
Pfizer Inc. (PFE)'s Toviaz Top-Line Primary Endpoint Results Positive in Overactive Bladder Study of Nocturnal Urinary Urgency     11/8/2011
FDA Approves Allergan Inc. (AGN)'s Botox to Treat Specific Form of Urinary Incontinence     8/25/2011
Hyperion Therapeutics Receives FDA Fast Track Designation for Glycerol Phenylbutyrate for the Treatment of Urea Cycle Disorders     10/18/2010
Cubist Pharmaceuticals, Inc. (CBST) Says Urinary Infection Drug Meets Study Goals     6/30/2010
Endo Pharmaceuticals (ENDP) to Buy HealthTronics (HTRN) for $223 Million     5/6/2010
Ranbaxy Laboratories (RANBAXY.BO) Unable to Launch New Generic, Flomax; Shares Fall     3/3/2010
Sosei Co., Ltd. Discontinues Development Of SOU-001     5/15/2006
Pfizer Inc. (PFE) To Buy Schwarz Pharma Bladder Drug For $210 Million; Schwarz Shares Surge     4/13/2006
Nippon Chemiphar Co., Ltd. And Torii Pharmaceutical Co. To Terminate Sales Tie-Up For Urinary Alkalizer     3/14/2006

News from Around the Web
Botox Beats Implant For Urinary Incontinence In Women, Duke University Study     10/6/2016
New Soft Material Could Reduce Complications For Women Suffering From Urinary Incontinence, University of Sheffield Study     3/17/2016
Medical College of Georgia Researchers Find Gene for Rare Syndrome     6/18/2010
Stress Incontinence Treatments Work Equally Well, University of Alabama at Birmingham Study     5/18/2010
Asia's Party Drug Ketamine Carries Incontinence Risk     6/26/2009
Gel Effective For Women With Overactive Bladder, Vanderbilt University Medical Center Study     5/5/2009
Muscle Cells Cut Urinary Incontinence, University of Toronto Study     4/27/2009
National Institutes of Health (NIH) State-of-the-Science Panel Seeks to Dispel Stigma Associated With Fecal and Urinary Incontinence     12/13/2007
Cell Transplants May Improve Severe Urinary Incontinence     11/13/2007
Removal Of Uterus Increases Risk Of Urinary Incontinence     10/30/2007
New Male Sling Procedure Helps Prostate Cancer Survivors Who Suffer from Urinary Incontinence     8/29/2007
Acute Sleep Deprivation Leads To Changes In Nighttime Urine Production For Men And Women     8/9/2007
A Simple Injection of Stem Cells from a Woman's Own Muscle May be an Effective Long-Term Treatment for Urinary Incontinence, University of Pittsburgh Study Finds     5/22/2007
Sling Surgery is More Effective than Burch for Bladder Control in Women     5/22/2007
Cornell University's Quick, Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy     5/14/2007

Press Releases
Medtronic (MDT) Release: Five-Year Data Demonstrate Interstim Therapy Offers Sustained Long-Term Efficacy And Quality Of Life Improvements For Overactive Bladder Patients     7/17/2017
GTx, Inc. (GTXI) Announces Positive Preliminary Results From Ongoing Phase II Proof-Of-Concept Clinical Trial In Women With Stress Urinary Incontinence     6/12/2017
Solace Therapeutics, Inc. Release: A Third Randomized Controlled Trial (RCT) Of The Vesair Bladder Control System For The Treatment Of Stress Urinary Incontinence Delivers Promising Results     3/1/2017
Stimguard Enrolls First Patient In Office-Based Chronic Tibial Nerve OAB Incontinence Stimulation Study Utilizing The World’s Smallest Wireless System     12/15/2016
Innovus Pharma Launches Its Clinically Proven Urivarx Product For Bladder Health Through Its Beyond Human Sales And Marketing Platform In The United States     12/1/2016
Allergan (AGN) Release: FDA Advisory Committee Recommends Approval Of SER120 (Desmopressin Nasal Spray)     10/21/2016
BioLife Solutions, Inc. (BLFS.OB) Products Embedded In Cook MyoSite Phase 3 Cell Therapy Clinical Trial For Stress Urinary Incontinence     7/18/2016
SRS Medical Systems Receives CE Mark Approval for Spanner Prostate Stent     6/29/2016
Cytori Therapeutics (CYTX) Cell Therapy Leads To Improved Function And Reduced Scar Tissue In A Urinary Injury Model     6/10/2016
Sophiris Bio (SPHS) To Present Topsalysin Phase 3 Data From Positive PLUS-1 Study As A Late Breaking Poster During The 111th American Urological Association Annual Meeting     5/6/2016
Juniper Pharma (JNP) Affirms Development Pathway For Oxybutynin Intra-Vaginal Ring For Overactive Bladder In Women     3/21/2016
GTx, Inc. (GTXI) Announces Presentation Of Preclinical Data Demonstrating The Effect Of GTx SARMs On Pelvic Floor Muscle Loss At The Society Of Urodynamics, Female Pelvic Medicine And Urogenital Reconstruction (SUFU) Meeting     2/24/2016
GTX Corp Announces Initiation Of Phase 2 Clinical Trial Of Enobosarm In Stress Urinary Incontinence     1/13/2016
Allergan (AGN) Announces New Long-Term OnabotulinumtoxinA Treatment Study Results At The American Urogynecologic Society Meeting     10/16/2015
Sandoz Canada Launches PrSandoz Solifenacin On The Canadian Market For The Treatment Of Urinary Urgency, Frequency And Incontinence     10/8/2015